Table 4.
Covariate | OR estimate | Lower 95% CI | Upper 95% CI | P-value |
---|---|---|---|---|
Male (vs female) | 1.203 | 1.085 | 1.335 | 0.0005 |
Age group, years (vs 18–34) | ||||
35–44 | 1.220 | 1.081 | 1.376 | 0.0013 |
45–54 | 1.331 | 1.178 | 1.505 | <0.0001 |
55–64 | 1.321 | 1.138 | 1.533 | 0.0003 |
Select comorbidities (vs none) | ||||
Anxiety | 1.047 | 0.917 | 1.195 | 0.4995 |
Arthritis (RA/OA) | 0.909 | 0.770 | 1.073 | 0.2586 |
Depression | 0.618 | 0.511 | 0.747 | <0.0001 |
Diabetes | 0.906 | 0.767 | 1.072 | 0.2505 |
Gastrointestinal disease | 0.893 | 0.795 | 1.003 | 0.0572 |
Hypertension | 0.939 | 0.841 | 1.049 | 0.2661 |
Thyroid disease | 0.947 | 0.838 | 1.069 | 0.3781 |
Self-injectable DMD (vs oral DMD) | 1.062 | 0.937 | 1.202 | 0.3473 |
Abbreviations: CI, confidence interval; DMD, disease-modifying drug; OA, osteoarthritis; OR, odds ratio; RA, rheumatoid arthritis.